6-氨基-5-硝基-3-吡啶羧酸 | 89488-06-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 6-氨基-5-硝基-3-吡啶羧酸
• 中文别名: 5-硝基-6-氨基烟酸
• 英文名称: 5-nitro-6-aminonicotinic acid
• 英文别名: 6-amino-5-nitronicotinic acid；6-amino-5-nitro-nicotinic acid；6-Amino-5-nitro-nicotinsaeure；6-amino-5-nitropyridine-3-carboxylic acid
• CAS: 89488-06-2
• 化学式: C₆H₅N₃O₄
• 分子量: 183.123
• InChiKey: JDDGLUVPISQPKN-UHFFFAOYSA-N

物化性质

• 熔点：
  300-301 °C (decomp)
• 沸点：
  435.9±45.0 °C(Predicted)
• 密度：
  1.675±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  122
• 氢给体数：
  2
• 氢受体数：
  6

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
• 危险性描述：
  H302,H312,H332

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Amino-5-nitropyridine-3-carboxylic acid
Synonyms: 2-Amino-3-nitropyridine-5-carboxylic acid

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Amino-5-nitropyridine-3-carboxylic acid
CAS number: 89488-06-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H5N3O4
Molecular weight: 183.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-氨基-5-硝基-3-吡啶羧酸 在 铁粉 氯化铵 作用下， 以 四氢呋喃 、 乙醇 、 水 为溶剂， 反应 54.0h， 生成 ethyl 6-amino-5-(1-aza-2-(2,4-dichlorophenyl)vinyl)nicotinate
  参考文献：
  名称：

  Sulfonamide compounds and medicinal use thereof

  摘要：

  化合物的化学式（I）为磺胺类化合物： R1—SO2NHCO—A—R2  （I） 其中R1为烷基，烯基，炔基等；A为除苯并咪唑基，吲哚基，4,7-二氢苯并咪唑基和2,3-二氢苯并噁嗪基之外的可选择取代的杂多环基团；X为烷基，氧杂环烷基等；R2为可选择取代的芳基，取代的联苯基等，其盐及包含其的药物组合物。该磺胺类化合物对于基于其降低血糖水平活性、cGMP-PDE（特别是PDE-V）抑制活性、平滑肌松弛活性、支气管扩张活性、血管扩张活性、平滑肌细胞抑制活性和抗过敏活性可治疗的疾病有效。

  公开号：

  US06348474B1
• 作为产物：
  描述：

  6-氯烟酸 在 硫酸 、 氨 、 硝酸 作用下， 生成 6-氨基-5-硝基-3-吡啶羧酸
  参考文献：
  名称：

  Marckwald, Chemische Berichte, 1893, vol. 26, p. 2189

  摘要：

  DOI：

文献信息

• IMIDAZOPYRIDINE COMPOUNDS
  申请人：Iwata Hidehisa

  公开号：US20100069431A1

  公开（公告）日：2010-03-18

  Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein.

  提供了用于与葡萄糖激酶一起使用的化合物、药物组合物、试剂盒和方法，其中包括从以下公式(I)所述的组中选择的化合物，其中变量如本文所定义。
• Thrombin inhibitors
  申请人：——

  公开号：US20020193398A1

  公开（公告）日：2002-12-19

  Compounds of the invention are useful in inhibiting thrombin and treating blood coagulation and cardiovascular disorders and have the following structure: 1 wherein R 3 is hydrogen or halogen, and u is N or CH.

  该发明的化合物在抑制凝血酶、治疗血液凝固和心血管疾病方面具有用处，并具有以下结构： 1 其中 R 3 为氢或卤素，u为N或CH。
• Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
  申请人：——

  公开号：US20040116466A1

  公开（公告）日：2004-06-17

  The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to phenyl-aza-benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. This invention further relates to small molecules which suppress cytokines and leukocytes.

  本发明涉及针对过敏原IgE反应的小分子抑制剂，该抑制剂在过敏和/或哮喘的治疗中很有用，或者在IgE是致病因素的任何疾病中也很有用。该发明还涉及苯基-氮杂苯并咪唑分子，这些分子是细胞增殖抑制剂，因此可用作抗癌药物。此外，该发明还涉及抑制细胞因子和白细胞的小分子。
• Sulfonamide compounds and uses thereof as medicines
  申请人：Fujisawa Pharmaceutical Co. Ltd.

  公开号：US06573274B1

  公开（公告）日：2003-06-03

  The present invention relates to a sulfonamide compound of the formula (I): wherein each symbol is as defined in the specification, a salt thereof, and a pharmaceutical composition containing same. This compound can be an effective agent for the prophylaxis and treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy suppressing action.

  本发明涉及一种具有以下结构式(I)的磺胺类化合物：其中每个符号如规范中定义，其盐以及含有该化合物的药物组合物。该化合物可以作为一种有效的药剂，用于预防和治疗基于降糖作用可治愈的疾病，以及基于cGMP-PDE抑制作用、平滑肌松弛作用、支气管扩张作用、血管扩张作用、平滑肌细胞抑制作用和抗过敏作用可治愈的疾病。
• Sulfonamide compounds and pharmaceutical use thereof
  申请人：Fujisawa Pharmaceutical Co. Ltd.

  公开号：US20020099212A1

  公开（公告）日：2002-07-25

  A sulfonamide compound of the formula (I): R 1 —SO 2 NHCO—A—X—R 2 (I) wherein R 1 is alky, alkenyl, alkynyl and the like; A is an optionally substituted heteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R 2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.

  化合物I的磺酰胺类化合物：R1-SO2NHCO-A-X-R2（I），其中R1是烷基，烯基，炔基等；A是可选取代的异杂多环基团，但不包括苯并咪唑基，吲哚基，4,7-二氢苯并咪唑基和2,3-二氢苯并噁唑基；X是烷基，氧杂环烷基，氧杂环（低）烷基等；R2是可选取代的芳基，取代联苯基等，其盐和药物组成物。该磺酰胺类化合物对于可基于其降低血糖水平的活性、cGMP-PDE（特别是PDE-V）抑制活性、平滑肌松弛活性、支气管扩张活性、血管扩张活性、平滑肌细胞抑制活性和抗过敏活性可治疗的疾病有效。